| WAVE LIFE SCIENCES LTD. |
| Singapur |
| Gesundheit |
| SG9999014716 / A1436W |
| 1U5 (Frankfurt) / WVE (NASDAQ) |
| FRA:1U5, ETR:1U5, 1U5:GR, NASDAQ:WVE |
| - |
| https://wavelifesciences... |
|
Wave Life Sciences Ltd. is a biotechnology company engaged in the research and development of stereopure nucleic acid therapies. The primary focus of Wave Life Sciences is to leverage its unique platf..
>Volltext.. |
| 1884.84 Mio. EUR |
| 1393.72 Mio. EUR |
| 36.82 Mio. EUR |
| -177.95 Mio. EUR |
| -176.1 Mio. EUR |
| -1.04 EUR |
| 15.31 Mio. EUR |
| 518.76 Mio. EUR |
| -162.85 Mio. EUR |
| 6.33 |
| -65.23% |
| -85.7% |
| - |
| - |
| - |
| WAVE LIFE SCIENCES |
| 26.03.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|